TABLE 3 Estimated Outcomes as a Function of IMR, estimated from linear mixed models in the Intention to treat sample Baseline Post treatment (12 months) Follow-up (18 months) N Mean (95% CI) Mean difference (95% CI) d N Mean (95% CI) Mean difference (95% CI) d N Mean (95% CI) Mean difference (95% CI) d PRIMARY OUTCOME IMRS client version Experimental 116 3.32 (3.22, 3.41) 0.03 (-0.11, 0.17) 0.06 99 3.43 (3.33, 3.53) 0.05 (-0.11, 0.22) 0.10 104 3.55 (3.45, 3.65) 0.17 (0.02, 0.33) 0.34* Control 71 3.29 (3.18, 3.39) 58 3.37 (3.25, 3.50) 61 3.38 (3.25, 3.50) SECONDARY OUTCOMES IMRS clinician version Experimental 116 3.25 (3.18, 3.33) 0.05 (-0.07, 0.17) 0.12 99 3.45 (3.36, 3.55) 0.15 (0.01, 0.29) 0.33 105 3.53 (3.43, 3.62) 0.14 (-0.01, 0.30) 0.29 Control 71 3.20 (3.11, 3.3) 61 3.3 (3.2, 3.40) 57 3.38 (3.26, 3.51) MSPSS Experimental 116 5.04 (4.77, 5.31) 0.34 (-0.11, 0.79) 0.23 99 5.11 (4.83, 5.38) 0.41 (-0.05, 0.88) 0.28 104 5.24 (4.95, 5.53) 0.28 (-0.16, 0.72) 0.19 Control 70 4.70 (4.34, 5.06) 58 4.69 (4.31, 5.07) 61 4.96 (4.63, 5.29) CSES Experimental 116 137.16 (127.94, 146.38) 6.38 (-8.65, 21.41) 0.13 99 146.69 (138.87, 154.51) 15.1 (1.22, 28.98) 0.34 104 150.58 (142.07, 159.09) 14.43 (0.26, 28.60) 0.31 Control 71 130.78 (118.91, 142.65) 58 131.58 (120.11, 143.05) 61 136.14 (124.81, 147.48) SES Experimental 115 10.79 (10.44, 11.13) 0.0 (-0.57, 0.56) 0.00 99 10.73 (10.37, 11.09) 0.16 (-0.46, 0.79) 0.08 105 10.81 (10.41, 11.2) -0.01 (-0.62, 0.61) 0.00 Control 71 10.79 (10.34, 11.23) 60 10.57 (10.06, 11.08) 56 10.82 (10.34, 11.29) IS Experimental 116 9.79 (9.33, 10.25) 0.39 (-0.52, 1.30) 0.14 99 9.83 (9.33, 10.33) 0.07 (-0.84, 0.99) 0.03 104 9.48 (8.88, 10.08) -0.08 (-1.08, 0.91) -0.03 Control 70 9.40 (8.62, 10.18) 57 9.75 (8.99, 10.52) 60 9.56 (8.76, 10.35) ASI Experimental 116 0.47 (0.25, 0.7) 0.02 (-0.31, 0.36) 0.02 99 0.27 (0.12, 0.42) -0.09 (-0.34, 0.17) -0.12 104 0.39 (0.14, 0.64) -0.03 (-0.38, 0.31) -0.03 Control 71 0.45 (0.2, 0.7) 58 0.36 (0.15, 0.57) 60 0.42 (0.18, 0.66) BSI Experimental 116 1.23 (1.07, 1.39) -0.09 (-0.34, 0.16) -0.11 99 1.15 (0.99, 1.3) -0.18 (-0.44, 0.08) -0.22 104 1.14 (0.98, 1.29) -0.08 (-0.34, 0.17) -0.10 Control 71 1.32 (1.13, 1.52) 58 1.33 (1.12, 1.54) 61 1.22 (1.02, 1.42) SFS Experimental 116 105.95 (104.33, 107.56) 1.08 (-1.44, 3.60) 0.12 99 106.56 (104.82, 108.3) 2.08 (-0.58, 4.73) 0.24 104 107.91 (106.2, 109.61) 1.9 (-0.85, 4.65) 0.21 Control 71 104.87 (102.93, 106.81) 58 104.48 (102.48, 106.49) 61 106.01 (103.85, 108.16) MHRM Experimental 116 70.15 (66.34, 73.96) 1.19 (-4.64, 7.03) 0.06 99 71.98 (68.13, 75.82) 4.24 (-1.88, 10.36) 0.21 104 74.05 (70.55, 77.56) 5.48 (-0.63, 11.58) 0.28 Control 71 68.96 (64.54, 73.38) 58 67.74 (62.98, 72.49) 61 68.58 (63.58, 73.58) SERS-SF Experimental 116 11.48 (7.18, 15.77) 4.57 (-2.46, 11.61) 0.19 99 14.74 (10.24, 19.24) 9.55 (2.85, 16.25) 0.43 104 17.64 (13.18, 22.11) 11.86 (4.95, 18.76) 0.52* Control 71 6.91 (1.34, 12.48) 58 5.18 (0.22, 10.15) 61 5.79 (0.52, 11.05) ISMI Experimental 116 2.10 (2,00, 2.19) -0.06 (-0.21, 0.10) -0.11 99 2.02 (1.93, 2.11) -0.19 (-0.35, -0.04) -0.41 104 2.01 (1.91, 2.11) -0.10 (-0.26, 0.06) -0.19 Control 71 2.16 (2.03, 2.28) 58 2.21 (2.08, 2.34) 61 2.11 (1.98, 2.23) * A treatment effect was found on this variable as reported in Table 2. IMRS= Illness Management and Recovery scale. MSPSS= Multidimensional Scale of Perceived Social Support. CSES= Coping SelfEfficacy Scale. SES= Service Engagement Scale, treatment adherence subscale; IS= Insight Scale. ASI= Addiction Severity Index, item 24. BSI = Brief Symptom Inventory. SFS= Social Functioning Scale MHRM= Mental Health Recovery Measure. SERS-SF= Self-Esteem Rating Scale-Short Form. ISMI= Internal Stigma of Mental Illness.
RkJQdWJsaXNoZXIy MjY0ODMw